SIBN SI-BONE, Inc.: Operating Margin

Corporate emblem and logo of SI-BONE Medical (SIBN)

The operating profitability assessment for SI-BONE, Inc. (SIBN) demonstrates revenue growth driven by the implementation of robotic production for titanium products. Business stability is based on surgeons' trust in safe sacral treatment methods and a streamlined sterile delivery system for implants. The current value has stabilized at -7.60, confirming the company's effective adaptation to market pressure and the high profitability of its core operations.

SIBN: SI-BONE Operating Margin 07/04/2022 - 11/19/2026

SI-BONE, Inc. - analytical breakdowns and key metrics (SIBN)

- share price and consensus valuation forecast:
Fundamental company analysis:SIBN, SI-BONE Inc
Brand item of SI-BONE Medical

Scaling the iFuse system and the increasing number of procedures directly enhance the operational efficiency of SI-BONE, Inc. (SIBN). This metric is calculated as the ratio of core business EBIT to total revenue. Investors utilize this coefficient to assess management's ability to control costs. Growth in this indicator confirms the high added value of the products. The trend in the operating margin reflects the actual resilience of the business model.

Competitors of SI-BONE, Inc. (SIBN)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Operating Margin|Operating Sales Margin OrthoPediatrics Corp. (KIDS)|Operating Margin TMCI|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)